InsiderSignal.AI

InsiderSignal.ai

JAZZ - Jazz Pharmaceuticals Plc

Insider Sale by Cozadd Bruce C (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Cozadd Bruce C, serving as Dir at Jazz Pharmaceuticals Plc (JAZZ), sold 6,000 shares at $190.50 per share, for a total transaction value of $1,143,010.00. Following this transaction, Cozadd Bruce C now holds 384,682 shares of JAZZ.

This sale represents a 2.00% decrease in Cozadd Bruce C's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, April 1, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 3, 2026, 2 days after the trade was made.

Jazz Pharmaceuticals Plc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Cozadd Bruce C

Dir

Bruce C. Cozadd is the co-founder, Chairman, and CEO of Jazz Pharmaceuticals, a global biopharmaceutical company specializing in innovative therapies for high unmet medical needs[[1]](https://axial.substack.com/p/bruce-cozadd-jazz-pharmaceuticals). He holds a Bachelor's degree from Yale University and an MBA from Stanford Graduate School of Business[[3]](https://www.marketscreener.com/insider/BRUCE-COZADD-A02I5X/). Cozadd's extensive career in the pharmaceutical industry began at ALZA Corporation, where he spent 10 years in various leadership roles, including Executive Vice President and Chief Operating Officer, before the company's acquisition by Johnson & Johnson in 2001[[1]](https://axial.substack.com/p/bruce-cozadd-jazz-pharmaceuticals). Under Cozadd's leadership since co-founding Jazz Pharmaceuticals in 2003, the company has become a leading biopharmaceutical firm, bringing over 11 therapeutics to market with a focus on neuroscience and oncology[[1]](https://axial.substack.com/p/bruce-cozadd-jazz-pharmaceuticals). His career has been defined by a commitment to developing life-changing treatments for conditions such as narcolepsy, excessive daytime sleepiness, and various forms of cancer[[1]](https://axial.substack.com/p/bruce-cozadd-jazz-pharmaceuticals). Beyond Jazz Pharmaceuticals, Cozadd serves on the boards of the Biotechnology Innovation Organization, Pharmaceutical Research & Manufacturers of America, and SFJAZZ, as well as serving as Chairman of The Nueva School[[3]](https://www.marketscreener.com/insider/BRUCE-COZADD-A02I5X/).

View full insider profile →

Trade Price

$190.50

Quantity

6,000

Total Value

$1,143,010.00

Shares Owned

384,682

Trade Date

Wednesday, April 1, 2026

4 days ago

SEC Filing Date

Friday, April 3, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Jazz Pharmaceuticals Plc

Company Overview

No company information available
View news mentioning JAZZ

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5334960

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime